Clinical trial
Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious…
NCT00407147 · Brahms AG, Industry · Terminated
Key facts
| NCT number | NCT00407147 |
|---|---|
| Title | Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection |
| Official title | ProBac - Use of Procalcitonin Level as Part of a Decision Tree to Discontinue Antibiotics When Started Empirically in the ICU in Hemodynamically Stable Patients With no Site of Infection Identified |
| Lead sponsor | Brahms AG, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Infection, Bacterial Infection, Sepsis |
| Intervention type | Device |
| Interventions | Procalcitonin assay - B.R.A.H.M.S PCT sensitive Kryptor |
| Enrollment | 11 |
| Start date | Jul 1, 2008 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Dec 4, 2006 |
| Last update posted | Jan 18, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: